Why women say yes to prenatal diagnosis.

[1]  N. Press,et al.  The production of authoritative knowledge in American prenatal care. , 1996, Medical anthropology quarterly.

[2]  Ellen S. Lazarus,et al.  What Do Women Want?: Issues of Choice, Control, and Class in Pregnancy and Childbirth , 1994 .

[3]  F. Meaney,et al.  Providers and consumers of prenatal genetic testing services: what do the national data tell us? , 1993, Fetal diagnosis and therapy.

[4]  N. Press,et al.  'Collective fictions': similarities in reasons for accepting maternal serum alpha-fetoprotein screening among women of diverse ethnic and social class backgrounds. , 1993, Fetal diagnosis and therapy.

[5]  M. Luxenberg,et al.  Maternal serum alpha-fetoprotein testing: physician experience and attitudes and their influence on patient acceptance. , 1992, The Journal of family practice.

[6]  A. Clarke.  Is non-directive genetic counselling possible? , 1991, The Lancet.

[7]  N. Holtzman.  What drives neonatal screening programs? , 1991, The New England journal of medicine.

[8]  M. Hopmann,et al.  Anxiety in women with low maternal serum alpha‐fetoprotein screening results , 1991, Prenatal diagnosis.

[9]  D. Paintin.  Effective Care in Pregnancy and Childbirth , 1990, British journal of obstetrics and gynaecology.

[10]  T. Marteau,et al.  Factors influencing the uptake of screening for open neural‐tube defects and amniocentesis to test for Down's syndrome , 1989, British journal of obstetrics and gynaecology.

[11]  M. Evans,et al.  Determinants of altered anxiety after abnormal maternal serum α-fetoprotein screening , 1988 .

[12]  P. Bjurulf,et al.  Pregnant Women's Attitudes and Knowledge in Relation to Access to Serum-Alpha-Fetoprotein Test , 1988, Scandinavian journal of social medicine.

[13]  K. Byrne-Essif,et al.  Acceptance of maternal alpha-fetoprotein screening in Wilmington hospital's obstetrical clinic. , 1988, Delaware medical journal.

[14]  F. Greenberg,et al.  The impact of MSAFP screening on genetic services, 1984-1986. , 1988, American journal of medical genetics.

[15]  C. Cummins,et al.  Factors affecting the uptake of screening for neural tube defect , 1988, British journal of obstetrics and gynaecology.

[16]  G. Valentine,et al.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[17]  R. Sokol,et al.  Establishment of a collaborative university-commercial maternal serum alpha-fetoprotein screening program: a model for tertiary center outreach. , 1987, American journal of obstetrics and gynecology.

[18]  Barbara Katz Rothman,et al.  The Politics and Practice of Abortion@@@From Crime to Choice: The Transformation of Abortion in America.@@@The Tentative Pregnancy: Prenatal Diagnosis and the Future of Motherhood. , 1987 .

[19]  N. Holtzman,et al.  Prenatal screening and pregnant women's attitudes toward the abortion of defective fetuses. , 1987, American journal of public health.

[20]  R. Hubbard.  Eugenics and Prenatal Testing , 1986, International journal of health services : planning, administration, evaluation.

[21]  G. Annas.  Is a genetic screening test ready when the lawyers say it is? , 1985, The Hastings Center report.

[22]  Walter E. Johnson,et al.  An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities , 1984 .

[23]  B. Kjessler,et al.  Who Declines from Antenatal Serum α‐Fetoprotein Screening and Why? , 1984 .

[24]  S. Mick,et al.  Women's attitudes toward the serum alpha-fetoprotein test. , 1983, Connecticut medicine.

[25]  G. Elder,et al.  THE EFFICACY OF A SERUM SCREENING SERVICE FOR NEURAL-TUBE DEFECTS: THE SOUTH WALES EXPERIENCE , 1983, The Lancet.

[26]  J. Mckinlay.  From "promising report" to "standard procedure": seven stages in the career of a medical innovation. , 1981, The Milbank Memorial Fund quarterly. Health and society.

[27]  B. Burton,et al.  Maternal serum alpha-fetoprotein screening: a report of the Forsyth County project. , 1981, American journal of obstetrics and gynecology.

[28]  Margarita B. Melville.  Twice a Minority: Mexican-American Women , 1980 .

[29]  M. J. Bennett,et al.  WOMEN'S ATTITUDES TO SCREENING FOR NEURAL TUBE DEFECTS , 1980, British journal of obstetrics and gynaecology.

[30]  J. Haddow,et al.  Screening for neural tube defects in the United States. A summary of the Scarborough Conference. , 1979, American journal of obstetrics and gynecology.

[31]  A M Foltz,et al.  The annual Pap test: a dubious policy success. , 1978, The Milbank Memorial Fund quarterly. Health and society.

[32]  N J Wald,et al.  MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENT IN ANTENATAL SCREENING FOR ANENCEPHALY AND SPINA BIFIDA IN EARLY PREGNANCY Report of U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects , 1977, The Lancet.

[33]  D. Brock,et al.  Prenatal diagnosis of anencephaly through maternal serum-alphafetoprotein measurement. , 1973, Lancet.

[34]  J. Green,et al.  Pregnant women's attitudes to abortion and prenatal screening , 1993 .

[35]  C. Overall.  The Future of human reproduction , 1992 .

[36]  T. Duster.  Backdoor to eugenics , 1990 .

[37]  Holtzman,et al.  Proceed With Caution: Predicting Genetic Risks In The Recombinant DNA Era , 1989 .

[38]  D. Mechanic.  From Advocacy to Allocation: The Evolving American Health Care System , 1986 .

[39]  B. Burton,et al.  The psychological impact of false positive elevations of maternal serum α-fetoprotein , 1985 .

[40]  S. Orbach,et al.  What Do Women Want , 1983 .

[41]  H. Waitzkin.  The Second Sickness: Contradictions of Capitalist Health Care , 1983 .

[42]  U. K. Collaborative Study.,et al.  Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. , 1977 .